Contrast-enhanced ultrasound of intrahepatic cholangiocarcinoma: Correlation with pathological examination

British Journal of Radiology

Volumn 85, Issue 1016, 2012, Pages 1029-1037

  Xu, Hui Xiong ^a,b   Chen, L D ^b   Liu, L N ^a   Zhang, Y F ^a   Guo, L H ^a   Liu, C ^a  

^a TONGJI UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER GROWTH; CANCER INFILTRATION; CARCINOMA CELL; CONTRAST ENHANCEMENT; ECHOGRAPHY; FEMALE; FIBROSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; STROMA; TUMOR CELL;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CONTRAST MEDIA; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PHOSPHOLIPIDS; RETROSPECTIVE STUDIES; SULFUR HEXAFLUORIDE; TUMOR BURDEN;

EID: 84864842486     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/21653786     Document Type: Article

References (20)

1. de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med 1999;341:1368-78.
2. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005;366:1303-14. (Pubitemid 41416587)
3. Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 2002;37:806-13. (Pubitemid 35404220)
4. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001;33:1353-7. (Pubitemid 32496970)
5. Taylor-Robinson SD, Toledano MB, Arora S, Keegan TJ, Hargreaves S, Beck A, et al. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 2001;48:816-20. (Pubitemid 32479209)
6. Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer. Jpn J Surg 1989;19:98-129.
7. Lim JH. Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol 2003;181:819-27. (Pubitemid 37021861)
8. Lim JH, Park CK. Pathology of cholangiocarcinoma. Abdom Imaging 2004;29:540-7. (Pubitemid 39095752)
9. Claudon M, Cosgrove D, Albrecht T, Bolondi L, Bosio M, Calliada F, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)-update 2008. Ultraschall Med 2008;29:28-44. (Pubitemid 351294171)
10. Chen LD, Xu HX, Xie XY, Lu MD, Xu ZF, Liu GJ, et al. Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT. Br J Radiol 2008;81:881-9.
11. Asayama Y, Yoshimitsu K, Irie H, Tajima T, Nishie A, Hirakawa M, et al. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology 2006;238:150-5. (Pubitemid 43010591)
12. Lacomis JM, Baron RL, Oliver JH, Nalesnik MA, Federle MP. Cholangiocarcinoma: delayed CT contrast enhancement patterns. Radiology 1997;203:98-104. (Pubitemid 27142714)
13. Yoshida Y, Imai Y, Murakami T, Nishikawa M, Kurokawa M, Yonezawa T, et al. Intrahepatic cholangiocarcinoma with marked hypervascularity. Abdom Imaging 1999;24:66-8. (Pubitemid 29036854)
14. Vilana R, Forner A, Bianchi L, García-Criado A, Rimola J, de Lope CR, et al. Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology 2010;51:2020-9.
15. Xu HX, Liu GJ, Lu MD, Xie XY, Xu ZF, Zheng YL, et al. Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent. J Clin Ultrasound 2006;34:261-72.
16. Xu HX, Lu MD, Liu GJ, Xie XY, Xu ZF, Zheng YL, et al. Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast enhanced sonography and SonoVue: initial experience. J Ultrasound Med 2006;25:23-33.
17. Chen LD, Xu HX, Xie XY, Xie XH, Xu ZF, Liu GJ, et al. Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound. Eur Radiol 2010;20:743-53.
18. Okamura N, Yoshida M, Shibuya A, Sugiura H, Okayasu I, Ohbu M. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas. Pathol Int 2005;55:724-31. (Pubitemid 41726939)
19. Maetani Y, Itoh K, Watanabe C, Shibata T, Ametani F, Yamabe H, et al. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roentgenol 2001;176:1499-507. (Pubitemid 32510270)
20. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-36. (Pubitemid 43112690)